XGBoost combining MRI radiomics and clinical biomarkers reportedly reaches C-index 0.782 for early brain tumor recurrence, but the paper's methods describe a liver-cancer cohort and no evaluation of its claimed temporal module appears.
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
1 Pith paper cite this work. Polarity classification is still indexing.
1
Pith paper citing it
citation-role summary
background 1
citation-polarity summary
fields
cs.LG 1years
2025 1verdicts
REJECT 1roles
background 1polarities
unclear 1representative citing papers
citing papers explorer
-
Multi-Modal Machine Learning Framework for Predicting Early Recurrence of Brain Tumors Using MRI and Clinical Biomarkers
XGBoost combining MRI radiomics and clinical biomarkers reportedly reaches C-index 0.782 for early brain tumor recurrence, but the paper's methods describe a liver-cancer cohort and no evaluation of its claimed temporal module appears.